189 related articles for article (PubMed ID: 24065161)
21. Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming.
Lee DH; Kim SH; Kang W; Choi YS; Lee SH; Lee SR; You S; Lee HK; Chang KT; Shin EC
Vaccine; 2011 Oct; 29(46):8293-301. PubMed ID: 21893142
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid A.
Velkov T; Soon RL; Chong PL; Huang JX; Cooper MA; Azad MA; Baker MA; Thompson PE; Roberts K; Nation RL; Clements A; Strugnell RA; Li J
Innate Immun; 2013 Jun; 19(3):265-77. PubMed ID: 23008349
[TBL] [Abstract][Full Text] [Related]
23. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
Front Immunol; 2021; 12():631797. PubMed ID: 33815382
[TBL] [Abstract][Full Text] [Related]
24. The acylation and phosphorylation pattern of lipid A from Xanthomonas campestris strongly influence its ability to trigger the innate immune response in Arabidopsis.
Silipo A; Sturiale L; Garozzo D; Erbs G; Jensen TT; Lanzetta R; Dow JM; Parrilli M; Newman MA; Molinaro A
Chembiochem; 2008 Apr; 9(6):896-904. PubMed ID: 18350528
[TBL] [Abstract][Full Text] [Related]
25. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
26. The structurally similar, penta-acylated lipopolysaccharides of Porphyromonas gingivalis and Bacteroides elicit strikingly different innate immune responses.
Berezow AB; Ernst RK; Coats SR; Braham PH; Karimi-Naser LM; Darveau RP
Microb Pathog; 2009 Aug; 47(2):68-77. PubMed ID: 19460428
[TBL] [Abstract][Full Text] [Related]
27. Structural and biological characterisation of a novel tetra-acyl lipid A from Escherichia coli F515 lipopolysaccharide acting as endotoxin antagonist in human monocytes.
Zähringer U; Salvetzki R; Wagner F; Lindner B; Ulmer AJ
J Endotoxin Res; 2001; 7(2):133-46. PubMed ID: 11521094
[TBL] [Abstract][Full Text] [Related]
28. Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract.
Bäckhed F; Söderhäll M; Ekman P; Normark S; Richter-Dahlfors A
Cell Microbiol; 2001 Mar; 3(3):153-8. PubMed ID: 11260138
[TBL] [Abstract][Full Text] [Related]
29. Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-κB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts.
Herath TD; Darveau RP; Seneviratne CJ; Wang CY; Wang Y; Jin L
PLoS One; 2013; 8(3):e58496. PubMed ID: 23554896
[TBL] [Abstract][Full Text] [Related]
30. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells.
Tanamoto K; Azumi S
J Immunol; 2000 Mar; 164(6):3149-56. PubMed ID: 10706705
[TBL] [Abstract][Full Text] [Related]
31. Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo2-Monophosphoryl-Lipid A or Kdo2-Pentaacyl-Monophosphoryl-Lipid A.
Wang B; Han Y; Li Y; Li Y; Wang X
PLoS One; 2015; 10(12):e0144714. PubMed ID: 26710252
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 4-dependent recognition of structurally different forms of chemically synthesized lipid As of Porphyromonas gingivalis.
Sawada N; Ogawa T; Asai Y; Makimura Y; Sugiyama A
Clin Exp Immunol; 2007 Jun; 148(3):529-36. PubMed ID: 17335558
[TBL] [Abstract][Full Text] [Related]
33. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
mBio; 2017 May; 8(3):. PubMed ID: 28487429
[TBL] [Abstract][Full Text] [Related]
34. Reinforcing Lipid A Acylation on the Cell Surface of Acinetobacter baumannii Promotes Cationic Antimicrobial Peptide Resistance and Desiccation Survival.
Boll JM; Tucker AT; Klein DR; Beltran AM; Brodbelt JS; Davies BW; Trent MS
mBio; 2015 May; 6(3):e00478-15. PubMed ID: 25991684
[TBL] [Abstract][Full Text] [Related]
35. Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.
Giordano NP; Cian MB; Dalebroux ZD
Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32253250
[TBL] [Abstract][Full Text] [Related]
36. MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex.
Coats SR; Pham TT; Bainbridge BW; Reife RA; Darveau RP
J Immunol; 2005 Oct; 175(7):4490-8. PubMed ID: 16177092
[TBL] [Abstract][Full Text] [Related]
37. Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharide.
Zariri A; Pupo E; van Riet E; van Putten JP; van der Ley P
Sci Rep; 2016 Nov; 6():36575. PubMed ID: 27841285
[TBL] [Abstract][Full Text] [Related]
38. Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.
Ledov VA; Golovina ME; Markina AA; Knirel YA; L'vov VL; Kovalchuk AL; Aparin PG
Vaccine; 2019 Feb; 37(8):1062-1072. PubMed ID: 30670300
[TBL] [Abstract][Full Text] [Related]
39. Predominant phosphorylation patterns in
John CM; Phillips NJ; Jarvis GA
J Lipid Res; 2020 Nov; 61(11):1437-1449. PubMed ID: 32839198
[TBL] [Abstract][Full Text] [Related]
40. Association between lipid-A-producing oral bacteria of different potency and fractional exhaled nitric oxide in a Norwegian population-based adult cohort.
Khomich M; Lin H; Malinovschi A; Brix S; Cestelli L; Peddada S; Johannessen A; Eriksen C; Real FG; Svanes C; Bertelsen RJ
J Transl Med; 2023 May; 21(1):354. PubMed ID: 37246224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
